Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
UBS
Express Scripts
QuintilesIMS
Covington
Merck
Queensland Health
Daiichi Sankyo
Harvard Business School
Dow

Generated: February 19, 2018

DrugPatentWatch Database Preview

Piramal Critical Company Profile

« Back to Dashboard

What is the competitive landscape for PIRAMAL CRITICAL, and what generic and branded alternatives to PIRAMAL CRITICAL drugs are available?

PIRAMAL CRITICAL has five approved drugs.



Summary for Piramal Critical
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Piramal Critical

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical LEVOTHYROXINE SODIUM levothyroxine sodium POWDER;INTRAVENOUS 206163-001 Jun 29, 2016 AP RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical LEVOTHYROXINE SODIUM levothyroxine sodium POWDER;INTRAVENOUS 206163-002 Jun 29, 2016 AP RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-004 Jun 22, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-001 Nov 19, 2010 AP RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical SOJOURN sevoflurane LIQUID;INHALATION 077867-001 May 2, 2007 AN RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-003 Nov 19, 2010 AP RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical ENFLURANE enflurane LIQUID;INHALATION 074396-001 Jul 29, 1994 DISCN No No ➤ Sign Up ➤ Sign Up
Piramal Critical ISOFLURANE isoflurane LIQUID;INHALATION 074416-001 Sep 30, 1994 AN RX No No ➤ Sign Up ➤ Sign Up
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-002 Nov 19, 2010 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PIRAMAL CRITICAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 5/1/2015
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 4/14/2015
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Boehringer Ingelheim
Moodys
Harvard Business School
Fish and Richardson
Medtronic
Teva
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot